XBiotech (XBIT)
NASDAQ:XBIT
Holding XBIT?
Track your performance easily

XBiotech (XBIT) Financial Statements

327 Followers

XBiotech Financial Overview

XBiotech's market cap is currently ―. The company's EPS TTM is $-1.01; its P/E ratio is -6.16; XBiotech is scheduled to report earnings on May 9, 2019, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue----$ 300.00K
Gross Profit----$ 284.00K
EBIT$ -8.59M$ -7.06M$ -8.67M$ -6.63M$ -5.10M
EBITDA$ -8.15M-$ -8.24M$ -6.19M$ -4.65M
Net Income Common Stockholders$ -4.63M$ -7.36M$ -8.74M$ 10.40M$ -3.20M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 200.02M$ 202.19M$ 204.77M$ 212.66M$ 217.48M
Total Assets$ 226.62M$ 229.60M$ 235.14M$ 242.12M$ 246.10M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -200.02M$ -202.19M$ -204.77M$ -212.66M$ -217.48M
Total Liabilities$ 7.77M$ 6.94M$ 6.07M$ 5.22M$ 5.70M
Stockholders Equity$ 218.85M$ 222.66M$ 229.06M$ 236.91M$ 240.40M
Cash Flow-
Free Cash Flow$ -3.55M-$ -9.21M$ -4.81M$ 2.57M
Operating Cash Flow$ -3.43M$ -1.49M$ -9.00M$ -4.81M$ 2.70M
Investing Cash Flow$ -115.00K$ 61.83M$ -195.00K$ 8.00K$ -3.91M
Financing Cash Flow-$ 5.00K$ -14.00K--
Currency in USD

XBiotech Earnings and Revenue History

XBiotech Debt to Assets

XBiotech Cash Flow

XBiotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis